PubMed, not ads
Every claim here traces back to peer-reviewed studies. We read the papers so you don't have to wade through marketing copy.
Mechanism over hype
Whether it's saw palmetto or GHK-Cu, we explain how it actually works on the follicle — not just whether someone on Reddit liked it.
Actual price-per-result
We compare cost-per-month, dose-per-dollar, and effectiveness — so you know whether the premium brand is worth the markup.
Latest Articles
Real reviews, real studies, real results.
Low-Dose Oral Minoxidil (LDOM) in 2026: The Complete Dosing & Safety Guide
Why dermatologists now prescribe 0.25–5 mg minoxidil pills for hair loss, the actual dosing ladder, what 1,404 patients tell us about safety, and when LDOM is the wrong call.
Minoxidil Side Effects in 2026: What the Real Data Says
The full side-effect profile of topical and oral minoxidil — dread shed, propylene glycol irritation, hypertrichosis, cardiac, cat toxicity — sorted by what RCTs actually report vs Reddit hearsay.
Finasteride vs Dutasteride for Hair Loss (2026): Which One, When, and Why
Dutasteride suppresses 90% of scalp DHT vs finasteride's 70% — but it's off-label, more expensive, and has a 5-week half-life. The actual head-to-head comparison and a decision tree.
The Hair Growth Cycle Explained (2026): Anagen, Catagen, Telogen, Exogen — and Why Every Treatment Targets One of Them
Every hair-loss treatment — minoxidil, finasteride, microneedling, even shedding from stress — is doing something specific to one phase of the hair cycle. Once you see the cycle clearly, the treatment landscape makes sense.
DHT and Hair Loss: How It Works, Why It Targets Some Follicles (2026)
DHT is the hormone that drives androgenetic alopecia — but it doesn't attack all hair the same way. The mechanism, the genetic susceptibility, and what actually happens when finasteride blocks it.
Finasteride Side Effects: What the Real RCT Data Shows (2026)
Forum threads paint finasteride as terrifying. The published trial data tells a more measured story. Here are the actual numbers — sexual, mood, prostate-related — across 14,000+ patients.